Mitsuaki Sawano, MD, PhD
Cards
About
Titles
Associate Research Scientist
Biography
Mitsuaki Sawano, MD, Ph.D. joined Yale/YNHH Center for Outcomes Research and Evaluation (CORE) in May 2022. Dr. Sawano obtained his medical degree from Keio University School of Medicine in Tokyo, Japan. Following his Internal Medicine residency at Kawasaki Municipal Hospital, he served as a board-certified cardiologist and outcomes researcher at Keio University Hospital, Department of Cardiology. Dr. Sawano furthered his education during his Ph.D. program at Keio University and Harvard Global Clinical Scholars Research Training Program, where he received training in statistics and epidemiology.
Dr. Sawano's recent endeavors include serving as a writing member for various guidelines such as the Japanese Circulation Society (JCS) 2023 Guideline on the Primary Prevention of Coronary Artery Disease, 2022 JCS Guideline Focused Update on Diagnosis and Treatment in Patients with Stable Coronary Artery Disease, Japanese Association of Cardiovascular Intervention and Therapeutics (CVIT) nationwide percutaneous coronary intervention registry committee, Japan Circulation Society, Japan International Young Community, and the Asian Pacific Society of Cardiology (APSC).
Dr. Sawano's research interests primarily focus on identifying optimal methods to interpret and implement evidence generated from clinical trials and real-world evidence in the United States to Asian countries while considering differences in race, ethnicity, and healthcare systems. With his extensive background working with Japanese clinical and epidemiologic study members and databases, Dr. Sawano seeks to compare them to NCDR and other US databases to examine key issues associated with cardiovascular health inequity at CORE.
Appointments
Cardiovascular Medicine
Associate Research ScientistPrimary
Other Departments & Organizations
Education & Training
- PhD
- Keio University School of Medicine, Graduate School of Clinical Research
- MD
- Keio University, School of Medicine (2008)
Research
Publications
Featured Publications
JCS 2022 Guideline Focused Update on Diagnosis and Treatment in Patients With Stable Coronary Artery Disease.
Nakano S, Kohsaka S, Chikamori T, Fukushima K, Kobayashi Y, Kozuma K, Manabe S, Matsuo H, Nakamura M, Ohno T, Sawano M, Toda K, Ueda Y, Yokoi H, Gatate Y, Kasai T, Kawase Y, Matsumoto N, Mori H, Nakazato R, Niimi N, Saito Y, Shintani A, Watanabe I, Watanabe Y, Ikari Y, Jinzaki M, Kosuge M, Nakajima K, Kimura T. JCS 2022 Guideline Focused Update on Diagnosis and Treatment in Patients With Stable Coronary Artery Disease. Circulation Journal : Official Journal Of The Japanese Circulation Society 2022, 86: 882-915. PMID: 35283401, DOI: 10.1253/circj.CJ-21-1041.Peer-Reviewed Reviews, Practice Guidelines, Standards, and Consensus StatementsBleeding avoidance strategies and percutaneous coronary intervention outcomes: A 10-year observation from a Japanese Multicenter Registry
Sawano M, Spertus J, Masoudi F, Rumsfeld J, Numasawa Y, Inohara T, Kennedy K, Ueda I, Miyata H, Fukuda K, Kohsaka S. Bleeding avoidance strategies and percutaneous coronary intervention outcomes: A 10-year observation from a Japanese Multicenter Registry. American Heart Journal 2021, 235: 113-124. PMID: 33472053, DOI: 10.1016/j.ahj.2021.01.010.Peer-Reviewed Original ResearchConceptsPercutaneous coronary interventionTransfemoral approachTransradial approachNational Cardiovascular Data Registry CathPCI RegistryVascular closure device usePercutaneous coronary intervention outcomesMultivariable logistic regression analysisClosure device useConsecutive PCI patientsJapanese multicenter registryAdjusted odds ratioLogistic regression analysisPCI patientsCathPCI RegistryCoronary interventionMulticenter registryBleeding rateJapanese patientsOdds ratioRisk scoreLower riskPatientsUS populationCathPCIJapanese populationPerformance of the MAGGIC heart failure risk score and its modification with the addition of discharge natriuretic peptides
Sawano M, Shiraishi Y, Kohsaka S, Nagai T, Goda A, Mizuno A, Sujino Y, Nagatomo Y, Kohno T, Anzai T, Fukuda K, Yoshikawa T. Performance of the MAGGIC heart failure risk score and its modification with the addition of discharge natriuretic peptides. ESC Heart Failure 2018, 5: 610-619. PMID: 29520978, PMCID: PMC6073038, DOI: 10.1002/ehf2.12278.Peer-Reviewed Original ResearchConceptsMAGGIC scoreBNP levelsB-type natriuretic peptide levelsAcute Heart Failure registryChronic Heart Failure (MAGGIC) scoreConsecutive acute HF patientsHeart failure patient outcomesHeart Failure Risk ScoreMeta-Analysis Global GroupAcute HF patientsHeart Failure RegistryHeart failure scoreProspective multicentre registryIncremental prognostic valueNatriuretic peptide levelsHeart failure patientsMulticentre registryHF patientsFailure patientsYear mortalityNatriuretic peptidePatient mortalityPrognostic valueMean ageJapanese RegistryContemporary use and trends in percutaneous coronary intervention in Japan: an outline of the J-PCI registry
Sawano M, Yamaji K, Kohsaka S, Inohara T, Numasawa Y, Ando H, Iida O, Shinke T, Ishii H, Amano T. Contemporary use and trends in percutaneous coronary intervention in Japan: an outline of the J-PCI registry. Cardiovascular Intervention And Therapeutics 2020, 35: 218-226. PMID: 32440831, PMCID: PMC7295726, DOI: 10.1007/s12928-020-00669-z.Peer-Reviewed Original ResearchDeclining Risk of Sudden Death in Heart Failure.
Sawano M, Kohsaka S, Fukuda K. Declining Risk of Sudden Death in Heart Failure. New England Journal Of Medicine 2017, 377: 1794. PMID: 29094861, DOI: 10.1056/nejmc1711901.Peer-Reviewed Original ResearchSex Difference in Outcomes of Acute Myocardial Infarction in Young Patients
Sawano M, Lu Y, Caraballo C, Mahajan S, Dreyer R, Lichtman J, D'Onofrio G, Spatz E, Khera R, Onuma O, Murugiah K, Spertus J, Krumholz H. Sex Difference in Outcomes of Acute Myocardial Infarction in Young Patients. Journal Of The American College Of Cardiology 2023, 81: 1797-1806. PMID: 37137590, DOI: 10.1016/j.jacc.2023.03.383.Peer-Reviewed Original ResearchConceptsAcute myocardial infarctionNoncardiac hospitalizationsSubdistribution HRYounger patientsMyocardial infarctionSex differencesYoung womenCause-specific hospitalizationsCause of hospitalizationWorse health statusSignificant sex disparityNoncardiovascular hospitalizationsVIRGO StudyIndex episodeAdverse outcomesIncidence rateHospitalizationHigh riskSex disparitiesHealth statusPatientsU.S. hospitalsWomenInfarctionOutcomes
2024
Association of Door-to-Balloon Time and one-Year Outcomes in hospital survivors of ST-elevation myocardial infarction
Sawano M, Kohsaka S, Murugiah K, Ishii H, Yamaji K, Takahashi J, Ozaki K, Amano T, Kozuma K. Association of Door-to-Balloon Time and one-Year Outcomes in hospital survivors of ST-elevation myocardial infarction. Journal Of Cardiology 2024 PMID: 38964710, DOI: 10.1016/j.jjcc.2024.06.009.Peer-Reviewed Original ResearchDoor-to-balloon timeST-elevation myocardial infarctionAdjusted hazard ratiosSurvivors of ST-elevation myocardial infarctionMyocardial infarctionPatients aged <Specific patient subgroupsAdverse cardiovascular eventsOne-year outcomesAcute coronary eventsRevascularization historyMACE riskCardiogenic shockCoronary revascularizationOutcomes RegistryCardiovascular eventsHospital survivorsPatient subgroupsCardiac arrestSubgroup analysisCardiovascular outcomesHazard ratioHigher comorbiditiesCoronary eventsPrimary preventionExcess Cardiovascular Mortality Among Black Americans 2000-2022: A JACC Report Card
Arun A, Sawano M, Lu Y, Warner F, Caraballo C, Khera R, Echols M, Yancy C, Krumholz H. Excess Cardiovascular Mortality Among Black Americans 2000-2022: A JACC Report Card. Journal Of The American College Of Cardiology 2024 PMID: 38901531, DOI: 10.1016/j.jacc.2024.06.004.Peer-Reviewed Original ResearchA Novel Risk Score for Major Bleeding in Japanese Patients with Non-Valvular Atrial Fibrillation: The J-RISK AF Study
Akao M, Tomita H, Nakai M, Kodani E, Suzuki S, Hayashi K, Sawano M, Goya M, Yamashita T, Fukuda K, Tsuda T, Isobe M, Toyoda K, Miyamoto Y, Okamura T, Sasahara Y, Okumura K, Group O. A Novel Risk Score for Major Bleeding in Japanese Patients with Non-Valvular Atrial Fibrillation: The J-RISK AF Study. Journal Of Atherosclerosis And Thrombosis 2024, 64842. PMID: 38811233, DOI: 10.5551/jat.64842.Peer-Reviewed Original ResearchNon-valvular atrial fibrillationOral anticoagulantsRisk stratification systemJapanese patientsHAS-BLEDAtrial fibrillationNon-valvular atrial fibrillation patientsMultivariate Cox proportional hazards analysisConcomitant antiplatelet agentsAF studyCox proportional hazards analysisRisk scoreStratification systemBleeding risk stratificationFollow-up periodNovel risk scoreProportional hazards analysisRisk of ischemic strokeAF RegistryNon-valvularBleeding historyMajor bleedingRisk stratificationAntiplatelet agentsBleedingThe PAX LC Trial: A Decentralized, Phase 2, Randomized, Double-blind Study of Nirmatrelvir/Ritonavir Compared with Placebo/Ritonavir for Long COVID
Krumholz H, Sawano M, Bhattacharjee B, Caraballo C, Khera R, Li S, Herrin J, Coppi A, Holub J, Henriquez Y, Johnson M, Goddard T, Rocco E, Hummel A, Al Mouslmani M, Putrino D, Carr K, Carvajal-Gonzalez S, Charnas L, De Jesus M, Ziegler F, Iwasaki A. The PAX LC Trial: A Decentralized, Phase 2, Randomized, Double-blind Study of Nirmatrelvir/Ritonavir Compared with Placebo/Ritonavir for Long COVID. The American Journal Of Medicine 2024 PMID: 38735354, DOI: 10.1016/j.amjmed.2024.04.030.Peer-Reviewed Original ResearchLC trialPROMIS-29Participants' homesTargeting viral persistencePlacebo-controlled trialDouble-blind studyElectronic health recordsCore Outcome MeasuresLong COVIDEQ-5D-5LRepeated measures analysisEvidence-based treatmentsPhase 2Double-blindParticipant-centred approachStudy drugPrimary endpointSecondary endpointsCommunity-dwellingHealth recordsHealthcare utilizationContiguous US statesViral persistencePatient groupDrug treatment
Links & Media
News
- July 02, 2024
Yale Faculty Members Named to JACC Editorial Board
- May 28, 2024
Next Generation Research Uses Real-World Data to Identify Most Effective Hypertension Drugs for Patients
- April 01, 2024
Yale Faculty Present Groundbreaking Clinical Research at the 2024 American College of Cardiology Scientific Sessions
- May 11, 2023
Welcome New Staff, Postdocs, Postgrads & Faculty (May 2023)